167 related articles for article (PubMed ID: 30855480)
1. PBK/TOPK overexpression and survival in solid tumors: A PRISMA-compliant meta-analysis.
Xu M; Xu S
Medicine (Baltimore); 2019 Mar; 98(10):e14766. PubMed ID: 30855480
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of PDZ-Binding Kinase/T-LAK Cell-Originated Protein Kinase (PBK/TOPK) in Patients with Cancer.
Zhang Y; Yang X; Wang R; Zhang X
J Cancer; 2019; 10(1):131-137. PubMed ID: 30662533
[No Abstract] [Full Text] [Related]
3. PBK/TOPK Expression Predicts Prognosis in Oral Cancer.
Chang CF; Chen SL; Sung WW; Hsieh MJ; Hsu HT; Chen LH; Chen MK; Ko JL; Chen CJ; Chou MC
Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347940
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma.
Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Br J Cancer; 2017 Jan; 116(2):218-226. PubMed ID: 27898655
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of PBK/TOPK relates to poor prognosis of patients with breast cancer: a retrospective analysis.
Qiao L; Ba J; Xie J; Zhu R; Wan Y; Zhang M; Jin Z; Guo Z; Yu J; Chen S; Yao Y
World J Surg Oncol; 2022 Sep; 20(1):316. PubMed ID: 36171591
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
Su TC; Chen CY; Tsai WC; Hsu HT; Yen HH; Sung WW; Chen CJ
PLoS One; 2018; 13(10):e0204866. PubMed ID: 30286126
[TBL] [Abstract][Full Text] [Related]
7. PBK/TOPK expression correlates with mutant p53 and affects patients' prognosis and cell proliferation and viability in lung adenocarcinoma.
Lei B; Qi W; Zhao Y; Li Y; Liu S; Xu X; Zhi C; Wan L; Shen H
Hum Pathol; 2015 Feb; 46(2):217-24. PubMed ID: 25466965
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of PBK/TOPK Contributes to Tumor Development and Poor Outcome of Esophageal Squamous Cell Carcinoma.
Ohashi T; Komatsu S; Ichikawa D; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Anticancer Res; 2016 Dec; 36(12):6457-6466. PubMed ID: 27919968
[TBL] [Abstract][Full Text] [Related]
9. Tetraspanin CD151 as an emerging potential poor prognostic factor across solid tumors: a systematic review and meta-analysis.
Zeng P; Wang YH; Si M; Gu JH; Li P; Lu PH; Chen MB
Oncotarget; 2017 Jan; 8(3):5592-5602. PubMed ID: 27888619
[TBL] [Abstract][Full Text] [Related]
10. Impact of TROP2 expression on prognosis in solid tumors: A Systematic Review and Meta-analysis.
Zeng P; Chen MB; Zhou LN; Tang M; Liu CY; Lu PH
Sci Rep; 2016 Sep; 6():33658. PubMed ID: 27645103
[TBL] [Abstract][Full Text] [Related]
11. PBK/TOPK expression in non-small-cell lung cancer: its correlation and prognostic significance with Ki67 and p53 expression.
Lei B; Liu S; Qi W; Zhao Y; Li Y; Lin N; Xu X; Zhi C; Mei J; Yan Z; Wan L; Shen H
Histopathology; 2013 Nov; 63(5):696-703. PubMed ID: 24025073
[TBL] [Abstract][Full Text] [Related]
12. Mitotic kinase PBK/TOPK as a therapeutic target for adult T‑cell leukemia/lymphoma.
Ishikawa C; Senba M; Mori N
Int J Oncol; 2018 Aug; 53(2):801-814. PubMed ID: 29901068
[TBL] [Abstract][Full Text] [Related]
13. Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.
Joel M; Mughal AA; Grieg Z; Murrell W; Palmero S; Mikkelsen B; Fjerdingstad HB; Sandberg CJ; Behnan J; Glover JC; Langmoen IA; Stangeland B
Mol Cancer; 2015 Jun; 14():121. PubMed ID: 26081429
[TBL] [Abstract][Full Text] [Related]
14. Expression of PDZ-binding kinase/T-LAK cell-originated protein kinase (PBK/TOPK) in human urinary bladder transitional cell carcinoma.
Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
Immunobiology; 2014 Jun; 219(6):469-74. PubMed ID: 24629784
[TBL] [Abstract][Full Text] [Related]
15. PBK/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis.
Liu Y; Liu H; Cao H; Song B; Zhang W; Zhang W
Oncol Rep; 2015 Dec; 34(6):3288-96. PubMed ID: 26503118
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of NEK2 in human solid tumors: a systematic review and meta-analysis.
Wang X; Chen K; Liu H; Huang Z; Chen X; Yin L
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30578380
[TBL] [Abstract][Full Text] [Related]
17. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer.
Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM
Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732
[TBL] [Abstract][Full Text] [Related]
18. TMPRSS4 as an emerging potential poor prognostic factor for solid tumors: A systematic review and meta-analysis.
Zeng P; Zhang P; Zhou LN; Tang M; Shen YX; Jin J; Zhu YQ; Chen MB
Oncotarget; 2016 Nov; 7(46):76327-76336. PubMed ID: 27344186
[TBL] [Abstract][Full Text] [Related]
19. Gossypetin Inhibits Solar-UV Induced Cutaneous Basal Cell Carcinoma Through Direct Inhibiting PBK/TOPK Protein Kinase.
Wang L; Zhang Z; Ge R; Zhang J; Liu W; Mou K; Lv S; Mu X
Anticancer Agents Med Chem; 2019; 19(8):1029-1036. PubMed ID: 30827262
[TBL] [Abstract][Full Text] [Related]
20. PBK/TOPK: A Therapeutic Target Worthy of Attention.
Han Z; Li L; Huang Y; Zhao H; Luo Y
Cells; 2021 Feb; 10(2):. PubMed ID: 33670114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]